PDL BioPharma, Inc. EV/EBITDA

EV/EBITDA of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBITDA growth rates and interactive chart. EV/EBITDA is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA). The EV/EBITDA ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBITDA compared to a stock’s historical average or industry can indicate undervaluation.


Highlights and Quick Summary

Current EV/EBITDA of PDL BioPharma, Inc. is 0.0 (as of December 30, 2019)
  • EV/EBITDA for the quarter ending June 29, 2020 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly EV/EBITDA decreased by -100.0%
  • Annual EV/EBITDA for 2019 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBITDA for 2018 was 0.0 (a -100.0% decrease from previous year)
  • Annual EV/EBITDA for 2017 was 0.13 (a -94.25% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBITDA of PDL BioPharma, Inc.

Most recent EV/EBITDAof PDLI including historical data for past 10 years.

Interactive Chart of EV/EBITDA of PDL BioPharma, Inc.

PDL BioPharma, Inc. EV/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 0.0 0.0
2019 0.0 1.91 3.05 0.0 0.0
2018 0.0 0.0 0.0 0.71 0.0
2017 0.13 0.58 0.33 0.9 0.13
2016 2.35 1.89 1.34 0.94 2.35
2015 1.04 1.74 1.9 1.75 1.04
2014 2.13 2.08 3.19 2.44 2.13
2013 2.79 2.25 2.37 2.95 2.79
2012 3.04 3.47 2.87 2.91 3.04
2011 2.73 3.47 3.78 3.64 2.73
2010 0.0 0.0 0.0 0.0

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.